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Reduced MiR-675 in Exosome in H19 RNA-Related
Melanogenesis via MITF as a Direct Target
Nan-Hyung Kim1, Soo-Hyun Choi1, Chang-Hyun Kim1, Chang Hoon Lee2, Tae Ryong Lee3 and
Ai-Young Lee1
H19 non-coding RNA downregulation stimulates melanogenesis in melasma patients. However, its mechanism is
unclear. In this study, the potential role of a H19 microRNA, miR-675, in melanogenesis was examined. Real-time
PCR using cultured normal human skin keratinocytes, melanocytes, and fibroblasts with or without H19
knockdown showed accompanying changes between expression levels of H19 and those of miR-675 in
keratinocytes. MiR-675 was also detected in concentrated culture supernatants and showed expression levels
parallel with those of cell lysates. In addition to RNase resistance, FACS analysis showed anti-CD63-positive
exosomes in culture supernatants, suggesting miR-675 could be released extracellularly and delivered to
neighboring cells without degradation. In western blot analysis, the miR-675 mimic reduced the expression of
microphthalmia-associated transcription factor (MITF) and phosphorylation of cAMP-responsive element-binding
protein, extracellular signal–regulated kinase and apoptosis signal–regulating kinase, whereas these expressions
were increased by the miR-675 inhibitor. Although H19 was not a miR-675 target, luciferase reporter assay showed
a direct binding of miR-675 to 30-untranslated region of MITF. In addition, localized in vivomiR-675 overexpression
in mouse using a cationic polymer transfection reagent showed reduced mRNA expression levels of MITF,
tyrosinase, tyrosine-related protein-1 (Trp-1), and Trp-2. Collectively, the results suggest that miR-675 derived from
keratinocytes could be involved in H19-stimulated melanogenesis using MITF as a target of miR-675.
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INTRODUCTION
H19 downregulation is stimulated melanogenesis in melasma
patients (Kim et al., 2010). H19 RNA is a 2.3 kb long non-
coding RNA (Gabory et al., 2006). An important role of non-
coding RNAs is epigenetic regulation of genes. Epigenetic
modifications are mainly induced by methylation and
acetylation of histones and regulatory factors, DNA
methylation, and small non-coding RNAs (reviewed by
Bayarsaihan, 2011). As H19 consists of an imprinted cluster
with IGF2 and the imprinting control region between the two
genes (Jinno et al., 1996; Reese and Bartolomei, 2006),
methylation of maternal imprinting control region, which
results in simultaneous H19 gene downregulation and IGF2
overexpression, has mainly been considered as the
mechanism of H19 in tumorigenesis. However, there is no
clue as to whether melasma patients are in fact prone to
developing tumors. Methylation of maternal imprinting
control region has also been variable without a consistent
increase in hyperpigmented skin compared with normally
pigmented skin in patients, regardless of gender (Kim et al.,
2010). These findings suggest that a mechanism other than
DNA methylation may be involved in H19 downregulation-
induced melanogenesis.
MicroRNAs (miRNAs) are small, 20–24 nucleotides, endo-
genously expressed non-coding RNAs that regulate gene
expression post-transcriptionally by degradation or translational
inhibition of target mRNAs. As emerging evidence supports the
association between miRNAs and a broad range of pathological
conditions, such as cancer, cardiovascular diseases, diabetes,
liver diseases, respiratory diseases, psychiatric diseases, neuro-
logical diseases, and inflammatory and autoimmune diseases,
the discovery of miRNAs is one of the major scientific break-
throughs in the current field of cell biology and medical science
(reviewed by Ha, 2011). H19 RNA may give rise to miRNAs. In
particular, a 23-nucleotide miRNA, termed miR-675, has been
identified in human keratinocytes (Cai and Cullen, 2007).
Moreover, cells, which do not normally express H19,
transfected with H19 expression plasmid have been observed
to express miR-675, suggesting H19 as the origin of miR-675
(Cai and Cullen, 2007). The role of miR-675 has been presented
in relation to colorectal cancer (Tsang et al., 2010) and cartilage
recovery (Dudek et al., 2010; Steck et al., 2012). The role of
miR-675 in mammalian development has been suggested by
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inhibition of imprinted non-coding RNA expression through an
RNA interference mechanism (Cai and Cullen, 2007). An action
through a target has also been identified, such as a tumor-
suppressor retinoblastoma, which has found to be a direct target
of miR-675 (Tsang et al., 2010). In terms of miRNAs in skin
pigmentation, miR-25 has been presented to regulate the coat
color of alpacas (Zhu et al., 2010). However, no study has so far
been reported for the involvement of miR-675 in
melanogenesis.
It is also unclear how miR-675 exerts its action on
melanocytes if this miRNA originated from keratinocytes
(Cai and Cullen, 2007). In fact, H19-associated melano-
genesis was more obvious in co-cultures of H19 knockdown
keratinocytes and normal melanocytes compared with that of
monocultures of H19 knockdown melanocytes in a previous
study (Kim et al., 2010). Cell–cell communication may occur
through several ways, through receptors, direct cell–cell
contact, and cell–cell synapses. In addition, exosomes, which
are small membrane vesicles of endocytic origin released by
many cells into the extracellular environment, have been
identified to contain large amounts of intact and functional
small RNAs, including miRNAs. The transfer of exosome-
derived miRNAs to recipient cells has suggested to be a
mechanism allowing gene-based communication between
mammalian cells (Valadi et al., 2007).
Although H19 downregulation has been identified to be
involved in skin pigmentation of melasma, H19 is a non-
coding RNA. In this study, the role of miRNAs, particularly that
of miR-675, was examined as a potential mechanism behind
H19 RNA-related skin pigmentation. For the purpose, we
examined whether miR-675 is associated with H19, the type
of skin cells are involved in H19-related miR-675 expression,
and how miR-675 is involved in melanogenesis. As miRNAs
degrade or translationally inhibit their target mRNAs, micro-
phthalmia-associated transcription factor (MITF) was chosen as
a candidate target from a microarray analysis using miR-675
and database for miRNA target prediction (miRDB), and this
association was also experimentally validated. The results
showed that miR-675 is released from keratinocytes as exo-
somes and regulate H19 downregulation-induced melanogen-
esis through MITF as a direct target of miR-675.
RESULTS
H19 knockdown reduces miR-675 expression levels in
keratinocytes, but not in melanocytes
H19 RNA expression was examined in cultured normal
human epidermal keratinocytes, melanocytes, and in dermal
fibroblasts. Absolute expression levels decreased in order
in keratinocytes, melanocytes, and fibroblasts. The levels
in melanocytes and fibroblasts were much lower than those
in keratinocytes (Figure 1a). MiR-675 expression was also
examined in keratinocytes, melanocytes, and fibroblasts in the
absence or presence of H19 small interfering RNA (siRNA). In
keratinocytes, H19 knockdown significantly (Po0.05) redu-
ced the expression levels of miR-675 (Figure 1b). However,
H19 levels did not have a significant association with miR-675
expression levels in melanocytes (Figure 1c) and fibroblasts
(data not shown).
MiR-675 could be released from cultured keratinocytes into
culture media as exosomes
Expression levels of miR-675 correlated with those of H19 in
keratinocytes (Figure 1b), but not for melanocytes (Figure 1c)
nor fibroblasts (data not shown). As H19 knockdown in
keratinocytes increases melanogenesis and melanosome trans-
fer from co-cultured normal melanocytes (Kim et al., 2010), it
could be expected that miR-675 would induce similar results
in keratinocytes. However, it is unclear how miR-675 from
keratinocytes can influence melanocytes. Thus, we examined
whether miR-675 could be released extracellularly from
keratinocytes to exert a direct action on neighboring skin
cells. Real-time PCR showed that expression levels of miR-675
in cell lysates paralleled those in culture supernatants
(Figure 2a). Treatment of concentrated culture supernatants
with RNase did not reduce miR-675 expression levels
(Figure 2b). FACS analysis of the concentrated structures in
the supernatant, which were adsorbed with latex beads, then
stained with anti-CD63 antibody, also revealed that anti-
CD63-positive exosomes were present in concentrated culture
supernatants (Figure 2c).
miR-675 mimic reduces, whereas inhibitor stimulates
melanogenesis
Production of miR-675 was dependent on H19 levels in
keratinocytes (Figure 1b). Intracellular miR-675 was also
present in culture media as exosomes in keratinocytes
(Figure 2a–c), suggesting that miR-675 could be delivered by
exosomes to neighboring melanocytes and/or fibroblasts.
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Figure 1. miR-675 expression levels in keratinocytes and melanocytes with or
without H19 knockdown. (a) Absolute expression levels of H19 in
keratinocytes, melanocytes, and fibroblasts with or without H19 knockdown
using H19 small interfering RNA (siRNA). (b, c) Real-time PCR results for
relative ratios of H19 RNA and miR-675 expression levels in cultured normal
human epidermal keratinocytes (b) and melanocytes (c) with or without H19
knockdown using H19 siRNA. *Po0.05, data represent mean±SD of five
independent experiments. FB, fibroblast; KC, keratinocyte; MC, melanocyte.
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Therefore, the miR-675 mimic or inhibitor was transfected
into keratinocytes or fibroblasts, which were co-cultured
with normal melanocytes, or directly into melanocytes.
Subsequently, the effect of miR-675 on melanogenesis was
examined. The miR-675 mimic significantly (P40.05)
reduced the expression levels of tyrosinase in both co-cultured
systems (Figure 3a and b) and melanocyte monoculture
systems (Figure 3c), whereas the inhibitor increased these
expression levels (Figure 3a–c). In melanocyte monocultures,
the effects of miR-675 on the expression of tyrosinase,
tyrosine-related protein-1 (Trp-1), and Trp-2 were dose depen-
dent (Figure 3c). Western blot analysis to examine signaling
pathways involved in melanogenesis showed that the miR-675
mimic in melanocytes significantly (P40.05) reduced the
phosphorylation of cAMP-responsive element-binding protein
(CREB), extracellular signal–regulated kinase (ERK), apoptosis
signal–regulating kinase (AKT), and nuclear factor kappa B,
whereas the knockdown induced opposite results (Figure 3d).
Protein kinase C phosphorylation was not changed by either
the miR-675 mimic or the inhibitor (Figure 3d).
MiR-675 transfection results in no significant change in H19
expression levels in keratinocytes, melanocytes, and fibroblasts
As miR-675 has been suggested to inhibit the expression of
imprinted non-coding RNA through an RNA interference
mechanism (Cai and Cullen, 2007), we examined whether
miR-675 could reduce H19 expression levels in the same
manner as H19 siRNA did (Kim et al., 2010). As miR-675
could be delivered to neighboring cells as exosomes, the effect
of miR-675 on H19 expression levels was examined in
keratinocytes as well as melanocytes and fibroblasts. In
contrast to previous findings with regards to H19 siRNA,
miR-675 transfection using the mimic did not cause significant
changes to H19 expression levels in keratinocytes,
melanocytes, or fibroblasts (Figure 4a–c, respectively).
MiR-675 inhibits MITF expression by targeting its 30-untranslated
region (UTR)
The finding that miR-675 did not reduce H19 expression
levels (Figure 4a–c) indicates that H19 is not a direct target of
miR-675. MITF was suggested as a potential target of miR-675
by the microarray data obtained from cells treated with and
without the miR-675 mimic, showing 41.5-fold reduction
(Supplementary Table S1 online), and by MiRDB (http://
mirdb.org). Therefore, MITF was examined as a potential
direct target of miR-675, using cloned full-length 30-UTR
and deletion mutant of MITF. In fact, 7 bp of complementary
sequences were found between miR-675 and 30-UTR of MITF
mRNA (Figure 5a). Luciferase activity was reduced signifi-
cantly (Po0.05) in both 293T cell line (Figure 5b) and
cultured normal human melanocytes (Figure 5c), which were
transfected with pMIR-MITF (full length) and miR-675 but not
with the other combination of pMIR-REPORT/pMIR-MITF (full
length) and negative control miRNA/miR-675. In case of
deletion mutant MITF, miR-675 did not significantly reduce
luciferase activity in the 293T cell line or in melanocytes
(Figure 5b and c, respectively). In addition, the miR-675
mimic significantly (Po0.05) and dose-dependently reduced
expression levels of MITF mRNA and protein, whereas the
inhibitor significantly (Po0.05) and dose-dependently
increased the respective expression levels (Figure 5d).
In vivo delivery of miR-675 mimic reduced melanogenesis in
mouse skin
The effect of miR-675 on melanogenesis and association
between miR-675 and MITF was also examined in the biopsied
skin of C57BL/6J mice injected with the miR-675 3p mimic or
negative control with a cationic polymer transcription reagent,
in vivo-jetPEI (Polyplus-transfection SA, Illkirch, France). Trans-
fer of miR-675 3p into mouse skin reduced the mRNA
expression of MITF, tyrosinase, Trp-1, and Trp-2 (Figure 6a).
Immunohistochemistry also detected reduced tyrosinase and
MITF in the miR-675 3p transferred skin compared with the
normal control skin (Figure 6b and c, respectively).
DISCUSSION
H19 RNA gives rise to a group of miRNAs, of which miR-675
has been identified in human keratinocytes (Cai and Cullen,
2007) and colon cancer cell lines (Tsang et al., 2010). In this
study, H19 expression was examined in melanocytes and
fibroblasts, as well as in keratinocytes (Figure 1a). H19
expression has previously been identified in fibroblasts
(Hayashida et al., 1997; Stuhlmu¨ller et al., 2003). As
expected, miR-675 expression was identified in melanocytes
(Figure 1c) and fibroblasts (data not shown). Nonetheless,
an accompanied change between H19 and miR-675 was
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Figure 2. miR-675 expression in cell lysates versus supernatants of cultured
keratinocytes. (a) Real-time PCR results for relative ratios of H19 RNA and
miR-675 expression levels in cell lysates and supernatants of cultured normal
human epidermal keratinocytes, with or without H19 knockdown. (b) Real-
time PCR results for relative ratios of miR-675 expression levels in exosomes
purified from the culture supernatants (described in Materials and Methods
section), with or without RNase treatment. (c) FACS analysis results using anti-
CD63 antibody in purified exosomes (filled trace) or negative control (open
trace), which were absorbed onto latex beads. *Po0.05, data represent
mean±SD of five independent experiments. siRNA, small interfering RNA.
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required to identify whether miR-675 was involved in mela-
nogenesis. As H19 RNA downregulation is known to occur in
melanogenesis (Kim et al., 2010), miR-675 expression with or
without H19 knockdown using siRNA was examined in
keratinocytes, melanocytes, and fibroblasts cultured from
normal human skin. The result that expression levels of miR-
675 paralleled the expression levels of H19 RNA only in
keratinocytes (Figure 1b) suggested that miR-675 originates
from keratinocytes to mediate its role in melanogenesis.
Melanogenesis occurs in melanocytes. Therefore, transfer-
ence from keratinocytes to melanocytes could provide a
mechanism for miR-675 to inhibit melanogenesis. In fact,
concurrent presence of miR-675 in both cell lysates and
culture supernatants of keratinocytes (Figure 2a) suggested
extracellular release of miR-675. However, the presence of
extracellular miRNA may not necessarily signify a functional
cascade. A discrete mode of delivery to melanocytes and other
neighboring cells is required to prevent degradation and
to maintain the function of miR-675. Exosomes, which are
vesicles of endocytic origin released into the extracellular
environment, have been known to mediate a potential mode
of intercellular communication (Van Niel et al., 2006). In
addition, exosomes have been known to contain mRNAs and
miRNAs (Valadi et al., 2007; da Silveira et al., 2012).
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Exosome-derived mRNAs and miRNAs have been shown to
be resistant to RNase treatment and be functional after transfer
to recipient cells (Valadi et al., 2007). This study also showed
that RNase treatment did not significantly decrease miR-675
expression levels in keratinocyte culture supernatants
(Figure 2b). This result suggests that miR-675 was confined
inside a certain structure. In fact, FACS analysis showed that
the latex beads coated with a certain structure were reacted
with anti-CD63 antibody (Figure 2c), which indicated the
presence of exosomes (Clayton et al., 2001; Valadi et al.,
2007; da Silveira et al., 2012) in culture supernatants. To the
best of our knowledge, our experimental results showing an
involvement of miRNA within exosomes in intercellular
transfer from keratinocytes to melanocytes are previously
unreported.
As miR-675 can be transferred to neighboring cells through
exosomes (Figure 2b and c), miR-675 may exert its action in
melanocytes directly as well as indirectly through miR-675
containing keratinocytes or fibroblasts. Although no study has
reported the involvement of miR-675 in melanogenesis, this
study suggests that miR-675 inhibit melanogenesis in these
three common types of skin cells (Figure 3a–c). MITF-M is the
most critical transcriptional factor required for the regulation
of melanocyte function. CREB in cAMP pathway is a molecule
involved in activation of MITF-M (Widlund and Fisher, 2003).
To examine the mechanisms involved in the regulation of
melanogenesis, CREB was examined with protein kinase C
and AKT/protein kinase B (Gordon and Gilchrest, 1989; Park
et al., 2006). In this part of the experiment, the miR-675 mimic
decreased phosphorylations of CREB, ERK, AKT, and NF-kB,
whereas the miR-675 inhibitor increased the respective
phosphorylations (Figure 3d). This result suggested a regula-
tory role of cAMP, ERK, and AKT pathways in miR-675-related
melanogenesis, regardless of cell types.
Parallel changes were identified between miR-675 and
H19 in keratinocytes (Figure 1b). Nonetheless, miR-675 was
examined for its ability to inhibit H19 levels because
reductions in H19 RNA expression levels by H19 siRNA
are known to be associated with melanogenesis (Kim et al.,
2010). In contrast to H19 siRNA, however, miR-675
did not reduce H19 expression levels (Figure 4a–c), suggesting
that H19 is not a direct target of miR-675. On the other
hand, complementary sequences between 7 bp of miR-675
and 30-UTR of MITF (Figure 5a) suggested this site to be the
only miR-675 site in the transcript. Moreover, luciferase
reporter assays (Martin et al., 2006) showed that full-length
30-UTR, but not deletion mutant, of MITF reduced MITF
expression in two kinds of cells including normal human
melanocytes containing miR-675 mimic (Figure 5b and c).
This result indicates a direct binding of miR-675 to the 30-UTR
of MITF.
To confirm the involvement of miR-675 in melanogenesis
inhibition, in vitro results requires validation in an in vivo
model. As melasma is a hyperpigmented skin disorder affect-
ing particular locations, but neither the entire skin nor other
organs, localized percutaneous delivery of the miRNAs is a
potential mechanism worth investigating. In this study,
repeated subepidermal injection (Murase et al., 2009) of the
mouse miR-675 mimic or negative control with a cationic
polymer transfection reagent induced localized miR-675
overexpression in vivo, although the miR-675 overexpression
levels were quite different across various specimens. In
addition, mRNA expression levels of miR-675 were
reciprocal with those of MITF, tyrosinase, Trp-1, and Trp-2
in miR-675-overexpressed skin specimens (Figure 6a). Reci-
procal expressions were also identified in immunohistochem-
istry using anti-tyrosinase and anti-MITF antibodies in miR-
675-overexpressed skin specimens (Figure 6b and c, respec-
tively). Although the discrepancies among in vivo results may
be caused by a lack of organ or cell specificity in gene
delivery using non-viral vectors (Hashida et al., 2001), these
in vivo results help to confirm the role of miR-675 in H19
RNA downregulation-induced melanogenesis.
MATERIALS AND METHODS
Normal human epidermal cell culture
Adult skin specimens obtained from cesarean sections and circumci-
sions were used for establishing cells in culture. The epidermis was
separated from the dermis, and then suspensions of individual
epidermal cells were prepared. Keratinocytes were suspended in
EpiLife Medium (#M-EPI-500-CA; Invitrogen, Carlsbad, CA) supple-
mented with bovine pituitary extract, bovine insulin, hydrocortisone,
human epidermal growth factor, and bovine transferrin (#S-001-5;
Invitrogen). Keratinocytes from passages 3 or 4 were used in these
experiments. Melanocytes were suspended in medium 254 (Invitro-
gen) supplemented with bovine pituitary extract, fetal bovine serum,
bovine insulin, hydrocortisone, basic fibroblast growth factor, bovine
transferrin, heparin and phorbol 12-myristate 13-acetate (Invitrogen).
Melanocytes at passage numbers between 7 and 15 were used for
these experiments. For fibroblast culture, individual dermal cells were
suspended in DMEM (Gibco/BRL, Grand Island, NY) supplemented
with 10% fetal bovine serum (Gibco/BRL), 100 U ml–1 penicillin
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(Gibco/BRL), and 0.1 mg ml–1 streptomycin (Gibco/BRL). Fibroblasts
at passages between 5 and 10 were used.
Real-time reverse transcriptase–PCR analysis
The expression of mature miRNAs was assayed using Taqman
MicroRNA Assays (Applied Biosystems, Foster, CA) specific for
hsa-mir-675. TaqMan MicroRNA assays were used for miRNA
quantification by real-time reverse transcriptase–quantitative PCR.
Real-time quantitative PCR was performed with the Light Cycler480
probe master mix (Roche, Mannheim, Germany), and U18 was used
as a housekeeping gene for normalization (Applied Biosystems).
The levels of mRNAs relative to glyceraldehyde-3-phosphate
dehydrogenase were measured by quantitative real-time PCR using
the Light Cycler real-time PCR (Roche).
Exosome purification
Exosomes were prepared from the supernatant of keratinocytes by
differential centrifugation, as previously described (Hadi et al., 2007).
Briefly, cells were harvested and centrifuged at 500g for 10 minutes to
eliminate cells and then centrifuged again at 16,500 g for 20 minutes,
followed by filtration through a 0.22mm filter. Exosomes were
pelleted by ultracentrifugation at 120,000 g for 70 minutes.
Flow cytometry
For FACS analysis, exosomes from keratinocytes were adsorbed
onto 4mm aldehyde-sulphate latex beads (Interfacial Dynamics,
Tualatin, OR) and incubated with CD63- FITC antibody (Beckman
Coulter, Marseille, France). The cells were then washed thoroughly
with phosphate-buffered saline and prepared for flow cytometry.
Labeled cells were analyzed with a Cytomics FC500 flow cytometer
(Beckman Coulter, Hialeah, FL) using CXP software (Beckman
Coulter).
H19 knockdown
For the H19 downregulation, melanocytes and keratinocyte cultured
in six-well plates were transfected with two different stealthTM
siRNAs (Stealth 243 and Stealth 472) and a negative control stealth
siRNA (Invitrogen), using TransIT-siQUEST transfection reagent
(Mirus, PanVera, Madison, WI) and 80 nM siRNA, according to the
manufacturer’s instructions.
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region (UTR) of MITF mRNA. (b, c) Relative ratios of luciferase activity in the 293T cell line (b) and cultured normal human melanocytes (c), which were
transfected by pMIR-MITF full length (MITF) or pMIR-MITF deletion mutant (MITF mut), with or without miR-675. (d) Real-time PCR and western blot analysis of
MITF mRNA and protein expression in melanocytes treated with miR-675 mimic (miR675) or inhibitor (anti-miR675). *Po0.05, data represent mean±SD of five
independent experiments. The bold and lowercase letters denote 7bp of complementary sequence between miR-675 and 30URT of MITF.
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Transfection of miRNA mimics and inhibitors
Cells were transfected with negative control miRNA mimics
(Dharmacon Research, Lafayette, CO), human miR-675 mimics
(Dharmacon Research), negative control hairpin inhibitor, or
miR-675 hairpin inhibitor. The TransIT-siQUEST transfection reagent
(Mirus) was used for transfection according to the manufacturer’s
protocol.
Microarray
Total RNA from cells cultured under each condition was isolated
using QuickGene RNA cultured cell kit S (Life Science, Tokyo, Japan),
according to the manufacturer’s instructions. Arrays were prepared,
hybridized, and scanned at the local authorized Illumina array service
provider (MACROGEN, Seoul, South Korea). Total RNA was ampli-
fied and purified using the Ambion Illumina RNA amplification kit
(Ambion, Austin, TX) to yield biotinylated complementary RNA,
according to the manufacturer’s instructions. In all, 750 ng of labeled
complementary RNA, samples were hybridized to each human HT-
12 expression v.4 bead array for 16–18 hours at 58 1C, according to
the manufacturer’s instructions (Illumina, San Diego, CA). Detection
of array signal was carried out using Amersham fluorolink streptavi-
din-Cy3 (GE Healthcare Bio-Sciences, Little Chalfont, UK) following
the bead array manual. Arrays were scanned with an Illumina bead
array reader confocal scanner according to the manufacturer’s
instructions. The quality of hybridization and overall chip perfor-
mance were monitored by visual inspection of both internal quality
control checks and the raw scanned data. Raw data were extracted
using the software provided by the manufacturer (Illumina GenomeS-
tudio v2009.2; Gene Expression Module v1.5.4). Array data were
filtered by detection P-valueo0.05 (similar to signal to noise) in at
least 50% samples (we applied a filtering criterion for data analysis;
higher signal value was required to obtain a detection P-valueo0.05).
Selected gene signal value was transformed by logarithm and normal-
ized by quantile method.
Western blot analysis
Equal amounts of extracted proteins (20mg) were resolved using 10%
SDS-PAGE and were then transferred to nitrocellulose membranes.
The membranes were incubated with antibodies to phospho-ERK,
ERK, phospho-CREB, CREB, phospho-AKT, AKT, phospho-NF-kB,
NF-kB, phospho-protein kinase C, protein kinase C, beta-catenin
(rabbit polyclonal; Cell Signaling Technology, Beverly, MA), and
tyrosinase (goat polyclonal; Santa Cruz Biotechnology, Santa Cruz,
CA), and further with anti-rabbit or anti-mouse horseradish perox-
idase-conjugated antibodies (Santa Cruz Biotechnology), followed by
treatment with an enhanced chemiluminescence solution (Thermo,
Rockford, IL). Signals were captured on an Image Reader (LAS-3000;
Fuji Photo Film, Tokyo, Japan). To monitor the amount of protein
loaded in each lane, the membranes were reprobed with mouse
monoclonal anti-b-actin antibody (Sigma, St Louis, MO) and pro-
cessed as described above. Protein bands were analyzed by
densitometry.
Immunohistochemistry
For immunofluorescence staining, after deparaffinization and rehy-
dration, the sections were preincubated with 3% BSA. For double
staining, the cultured cells or sections were reacted sequentially with
anti-MITF, tyrosinase antibody and 1:200 Alexa Fluor-labeled goat
anti-rabbit IgG (488; Molecular Probes, Eugene, OR), and then with
anti-c-kit and Alexa Fluor-labeled mouse anti-mouse IgG (594;
Molecular Probes). Nuclei were counterstained with Hoechst 33258
(Sigma). The stained specimens were evaluated using an image
analysis system (Dp Manager 2.1; Olympus Optical, Tokyo, Japan).
Luciferase activity assay
Full-length human MITF 30-UTR was amplified by PCR using the
forward primer 50-AAAGCTGCGCACTAGTGAATGCAGAGAGAG
GAGAAG-30 (MITF-3UTR-F) and the reverse primer 50-ATCCTT
TATTAAGCTTTTGGATTTGCAAATGACT-30 (MITF-3UTR-R). The
amplified 30-UTR was cloned downstream of the luciferase gene in
Fold
miR-ctrl
miR675
*
*
*
*
*
20
15
10
3
2
1
0
miR675 3p
miR-ctrl
miR6753p
miR-ctrl
miR6753p
MITF
Tyrosinase Tyrosinase +Hoechst
Tyrosinase Tyrosinase +Hoechst
MITF +Hoechst
MITF +Hoechst
MITF
MITF
Tyrosinase TRP1 TRP2
R
el
at
ive
 e
xp
re
ss
io
n
Figure 6. In vivo delivery of miR-675 mimic on melanogenesis in mouse skin.
(a) Real-time PCR results for relative ratios of miR-675, microphthalmia-
associated transcription factor (MITF), tyrosinase, tyrosine-related protein-1
(Trp-1), and Trp-2 expression levels in mouse skin injected subepidermally
with mouse miR-675 3p or negative control miRNA using a cationic polymer
transfection reagent. *Po0.05, data represent mean±SD of five independent
experiments. (b, c) Immunohistochemical staining of mouse skin injected
mouse miR-675 3p or negative control miRNA using anti-tyrosinase (b) and
anti-MITF antibodies (c). Nuclei were counterstained with Hoechst 33258
(bar¼ 0.05 mm).
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pMIR-REPORT luciferase vector (Ambion). This construct, named
pMIR-MITF, was used for transfection in melanocytes and 293T. The
deletions were generated with the predicted target sites of MITF 30-
UTR using the QuickChange site-directed mutagenesis kit (Stratagene,
Lo Jolla, CA) according to the manufacturer’s instructions. Cells were
cultured in six-well plates, and each was transfected with pMIR-MITF
or pMIR-mutant together with pRL-TK vector (Promega, Madison, WI)
containing Renilla luciferase, and 50 nM of miR-675 or negative
control (Dharmacon Research). Transfection was done using Lipo-
fectamine 2000 (Invitrogen). Twenty-four hours after transfection,
firefly and Renilla luciferase activity were measured using the Dual-
Luciferase Reporter Assay (Promega). Transfection was performed in
triplicates, and all experiments were repeated three times.
Injection of miRNA into mouse
C57BL/6J female mice were used. The animal care and use commit-
tee of the research institute at Dongguk University Hospital approved
all described studies. Ears and back of each mouse were injected
subepidermally with 5mg of mouse miR-675 3p or negative control
miRNA with a cationic polymer transfection reagent, in vivo-jetPEITM
(Polyplus-transfection SA). In total, they were administrated with
miRNA injection three times at 24-hour intervals.
Statistical analysis
Statistical analysis of experimental data was performed using the
Student’s t-test. A P-value o0.05 was considered to be statistically
significant. All results are presented as mean±SD of the combined
data from repeated experiments.
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